Actively Recruiting
Texas Regional Excellence in Cancer (TREC) at Texas A&M University Cancer Prevention Registry and Repository
Led by Texas A&M University · Updated on 2025-02-13
2500
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting health and genetic information to better understand cancer prevention and treatment strategies. This observational study explores how genetics, diet, exercise, and occupation affect the risk of developing cancers that can be detected and treated early. The aim is to improve methods used by doctors and health insurers to prevent cancers that are currently difficult to treat. Participants will provide blood and urine samples as well as genetic material through buccal swabs for future research. The study will follow these participants' health records and any changes in health status over a five-year period. The collected information will be shared in a deidentified form with the research community to support ongoing cancer prevention efforts. Participants will be involved in providing consent, donating samples, and allowing their health records to be monitored for five years. Researchers will assess adverse drug reactions using the Naranjo Scale Questionnaire and track self-reported health status and significant changes during this time. The study aims to gather detailed data to inform cancer risk and prevention in a diverse population.
CONDITIONS
Brief Title
TREC@TAMU Cancer Prevention Registry and Repository
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age and older
- Participation in the CPRIT coordinated cancer screening program at Bryan and Navasota Family Medicine Clinics
- Diagnosis of COPD, liver disease, cervical intraepithelial neoplasia (CIN) lesions, or having had a colonoscopy, low dose computed tomography (LDCT) lung scan, or cervical exam in the last 12 months or scheduled for one
- Ability to understand and give informed consent
- Willingness to donate blood, urine, and genetic material through buccal swabs for future research
- Ability to understand that health records and changes in health status will be followed for five years and shared in deidentified form
- All sexes and gender identities are eligible
You will not qualify if you...
- Declines to participate or share medical status with staff
- Diagnosis of Alzheimer's disease or related dementias impairing memory, thought, or functioning
- Unable or unwilling to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Ongoing throughout the study
Participants donate blood, urine, and genetic material through buccal swabs for future research.
Visits scheduled as needed for sample collection
Duration - Up to 5 years
Participants' health status and medical records are followed for up to five years to track changes and study cancer risk factors.
Periodic visits depending on scheduled cancer screening or clinical appointments
Trial Site Locations
Total: 1 location
1
Texas A&M Family Care
Bryan, Texas, United States, 77802
Actively Recruiting
Research Team
K
Kenneth S Ramos, MD
R
Rick Silva, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here